3
86
Y. Fei et al. / Food Chemistry 187 (2015) 385–390
&
Erbas, 2005; Martinez-Force, Alvarez-Ortega, Cantisan, & Garces,
from Jiangxi Bencaotiangong Technology Co., Ltd. (Nanchang,
China). All of the other chemicals and reagents were of analytical
grade and purchased from Sinopharm Chemical Reagent Co., Ltd.
(Shanghai, China).
1
2
998; Rashid, Anwar, & Arif, 2009; Weisz, Kammerer, & Carle,
009). Recent studies reported more than twenty compounds iden-
tified from the seeds, and some of the compounds were found for
the first time from Helianthus genus (Amakura et al., 2013; Fei,
Chen, Li, Xu, & Yang, 2014). In this paper, we report the isolation
and structure identification of three new monoterpene glycosides
from sunflower seeds, together with eleven other compounds. In
addition, the results about the protective effects of these com-
2.2. Plant materials
The sunflower seeds (H. annuus L.) were purchased from a farm-
ers’ market in Qiqihar city (Heilongjiang province, China) in
September 2011 and authenticated by Prof. Xiaoran Li
pounds against cardiomyocytes injury induced by H
as their DPPH radical scavenging activities are included.
2 2
O , as well
(
Department of Pharmacognosy, College of Pharmaceutical
Science, Soochow University) using morphological identification.
A voucher specimen (No. 10-09-08-01) was deposited in the
herbarium of the College of Pharmaceutical Science at Soochow
University.
2
. Materials and methods
.1. Materials and chemicals
Melting points of the isolates were determined using the XT5
2
micro-melting-point system (Beijing Optical Instrument Factory,
Beijing, China). Specific optical rotation values were determined
using a 241 polarimeter (Perkin–Elmer Inc., Waltham, MA, USA).
IR spectra were recorded on a 983 G spectrometer (Perkin–Elmer
Inc., Waltham, MA, USA). H NMR, C NMR, and 2D NMR spectra
were obtained from an Inova 500 spectrometer (Varian Inc., Palo
2.3. Extraction and isolation
Sun-dried seeds (20 kg) were crushed into fine powder and
extracted twice in MeOH (200 L). The solvent was removed under
reduced pressure. The resulting residue (150 g) was dissolved in
distilled water and fractionated successively with petroleum ether,
chloroform, and n-butyl alcohol. The chloroform fraction (34 g)
was dissolved in chloroform, loaded onto a silica gel column, and
1
13
5 5
Alto, CA, USA) in C D N using tetramethylsilane (TMS) as the inter-
nal standard. HR-ESI-MS spectra were determined on a Q-TOF2
spectrometer (Micromass Corp., London, UK). EI-MS was deter-
mined on a Micromass Zabspec spectrometer (Micromass Corp.,
London, UK). High performance liquid chromatography (HPLC)
analysis and purification were performed with an Agilent Zorbax
eluted with CHCl
under reduced pressure. The CHCl
was subjected to separation on a MPLC/ODS column and eluted
with MeOH–H O (40:60, 60:40, 80:20, and 90:10; 1000 mL each)
3
–MeOH (80:20, 60:40, 40:60, 0:100; 4.0 L each)
3
–MeOH (60:40) eluate (6.2 g)
2
SB-C18 semipreparative HPLC column (250 ꢀ 9.4 mm i.d., 5
l
m,
at 20 mL/min to provide five fractions. Fraction 1 (196 mg) was
separated by Sephadex LH-20 gel column chromatography
(100 cm ꢀ 3 cm i.d.) eluting with MeOH to give compounds 6
Agilent Corp. Palo Alto, CA, USA) on a Shimadzu HPLC system com-
posed of a LC-20AT pump with an SPD-20A detector (Shimadzu
Corp., Kyoto, Japan), the flow rate was 2 mL/min, and the wave-
length for detection was 203 nm. Medium pressure liquid chro-
matography (MPLC) purification was performed on a Büchi Flash
Chromatography system composed of a C-650 pump with a flash
column (460 mm ꢀ 26 mm i.d., Büchi Corp., Flawil, Switzerland).
GC analysis was conducted on a GC-14C (Shimadzu Corp., Kyoto,
Japan) instrument with a flame ionization detector and the analyt-
ical conditions were as follows: DB-5 column (i.d. 0.25 mm, length
(43 mg) and 10 (32 mg). Compounds 7 (31 mg, t
R
13.27 min), 8
37.15 min) were obtained
from fraction 2 (163 mg) after separating by semi-preparative
RP-HPLC eluting with MeOH–H (67:33) at 2.0 mL/min.
Compounds 4 (15 mg, t 37.14 min), 3 (13 mg, t 14.61 min), 2
(15 mg, t 16.00 min), 5 (15 mg, t 26.61 min), and 1 (9.2 mg, t
32.70 min) were obtained from fraction 3 (120 mg) after the purifi-
cation using semi-preparative RP-HPLC with MeOH–H O (56:44)
for elution. Fraction 4 (90 mg), which was subjected to separation
by semi-preparative RP-HPLC and eluted with MeOH–H O (86:14),
yielded compounds 11 (32 mg, t 12.42 min) and 12 (19 mg, t
15.62 min). Compounds 13 (51 mg, t 28.16 min) and 14 (13 mg,
37.43 min) were obtained from fraction 5 (102 mg) after purifi-
R R
(7.2 mg, t 29.35 min) and 9 (6.4 mg, t
2
O
R
R
R
R
R
2
3
0 m; Suzhou Huitong Chromatography Technology Co., Ltd.,
Suzhou, China), column temperature at 210 °C; injector tempera-
ture at 270 °C; and detector temperature at 300 °C. The samples
2
R
R
(
1
lL) were injected manually into the column.
R
Silica gel (200–300 mesh) for column chromatography and pre-
t
R
coated silica gel TLC plates were purchased from Qingdao Marine
Chemical Factory. ODS for MPLC was purchased from Merck
KGaA (Darmstadt, Germany). Sephadex LH-20 for column chro-
matography was purchased from GE Healthcare Corp. (Beijing,
China). Compounds on TLC were colored by spraying 10% sulfuric
acid alcohol solution and heating. Vitamin E was purchased from
J&K Scientific Ltd. (Beijing, China). 3-(4,5-Dimethyl-2-thiazolyl)-
cation by using semi-preparative RP-HPLC with MeOH–H
(89:11) as the eluent.
2
O
2.3.1. (+)-Campholenol-10-O-b-
D-glucopyranoside (1)
(4S)-2,2,3-trimethyl-3-cyclopentene-1-ethanol-10-O-b-
D
-glu-
2
5
1
copyranoside. white powder; [
a]
D
ꢁ36 (c = 0.015, MeOH);
H
1
3
2
,5-diphenyl-2H-tetrazolium bromide (MTT), 1,1-diphenyl-2-
NMR (500 MHz, MeOD) and C NMR (125 MHz, MeOD) spectro-
picrylhydrazyl (DPPH) and phosphate buffered saline (PBS) were
purchased from Sigma–Aldrich Co. (St. Louis, MO, USA).
Dulbecco’s modified Eagle’s medium (DMEM), mitochondrial
dehydrogenase and fetal bovine serum (FBS) were purchased from
Gibco™ (Grand Island, NY, USA). Rat H9c2 cardiomyocytes were
obtained from the Cell Bank of the Chinese Academy of Sciences
scopic data are shown in Table 1; HR-ESI-MS (negative ion mode)
ꢁ
m/z 315.1813 ([MꢁH] , calcd for C16
28 6
H O ; 315.1808).
2.3.2. (+)-Campholenol-10-O-b-
glucopyranoside (2)
D-apiofuranosyl-(1 ? 6)-b-D-
(
Shanghai, China). 96-Well plates were obtained from Corning
Costar (Corning Costar, Cambridge, MA, USA). CD OD and CDCl
were obtained from Merck (Darmstadt, Germany). Methanol
MeOH) for HPLC analysis and purification was HPLC grade and
(4S)-2,2,3-trimethyl-3-cyclopentene-1-ethanol-10-O-b-D-apio-
25
3
3
furanosyl-(1 ? 6)-b-
(c = 0.016, MeOH); H NMR (500 MHz, MeOD) and
D
1
-glucopyranoside. white powder; [
a
]
D
ꢁ55
13
C NMR
(
(125 MHz, MeOD) spectroscopic data are shown in Table 1;
ꢁ
purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai,
China). Standard (+)-campholenol and (ꢁ)-myrtenol were obtained
HR-ESI-MS (negative ion mode) m/z 447.2236 ([MꢁH] , calcd for
21 36
C H O10; 447.2230).